Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone

Development of novel testing strategies to detect adverse human health effects is of interest to replace in vivo-based drug and chemical safety testing. The aim of the present study was to investigate whether physiologically based kinetic (PBK) modeling-facilitated conversion of in vitro toxicity data is an adequate approach to predict in vivo cardiotoxicity in humans. To enable evaluation of predictions made, methadone was selected as the model compound, being a compound for which data on both kinetics and cardiotoxicity in humans are available. A PBK model for methadone in humans was developed and evaluated against available kinetic data presenting an adequate match. Use of the developed PBK model to convert concentration–response curves for the effect of methadone on human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) in the so-called multi electrode array (MEA) assay resulted in predictions for in vivo dose–response curves for methadone-induced cardiotoxicity that matched the available in vivo data. The results also revealed differences in protein plasma binding of methadone to be a potential factor underlying variation between individuals with respect to sensitivity towards the cardiotoxic effects of methadone. The present study provides a proof-of-principle of using PBK modeling-based reverse dosimetry of in vitro data for the prediction of cardiotoxicity in humans, providing a novel testing strategy in cardiac safety studies.

Saved in:
Bibliographic Details
Main Authors: Shi, Miaoying, Bouwmeester, Hans, Rietjens, Ivonne M.C.M., Strikwold, Marije
Format: Article/Letter to editor biblioteca
Language:English
Subjects:Cardiac electrophysiology, Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM), Methadone, Physiologically based kinetic (PBK) modeling, Quantitative in vitro to in vivo extrapolation (QIVIVE), Reverse dosimetry,
Online Access:https://research.wur.nl/en/publications/integrating-in-vitro-data-and-physiologically-based-kinetic-model
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-565818
record_format koha
spelling dig-wur-nl-wurpubs-5658182024-08-14 Shi, Miaoying Bouwmeester, Hans Rietjens, Ivonne M.C.M. Strikwold, Marije Article/Letter to editor Archives of Toxicology 94 (2020) ISSN: 0340-5761 Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone 2020 Development of novel testing strategies to detect adverse human health effects is of interest to replace in vivo-based drug and chemical safety testing. The aim of the present study was to investigate whether physiologically based kinetic (PBK) modeling-facilitated conversion of in vitro toxicity data is an adequate approach to predict in vivo cardiotoxicity in humans. To enable evaluation of predictions made, methadone was selected as the model compound, being a compound for which data on both kinetics and cardiotoxicity in humans are available. A PBK model for methadone in humans was developed and evaluated against available kinetic data presenting an adequate match. Use of the developed PBK model to convert concentration–response curves for the effect of methadone on human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) in the so-called multi electrode array (MEA) assay resulted in predictions for in vivo dose–response curves for methadone-induced cardiotoxicity that matched the available in vivo data. The results also revealed differences in protein plasma binding of methadone to be a potential factor underlying variation between individuals with respect to sensitivity towards the cardiotoxic effects of methadone. The present study provides a proof-of-principle of using PBK modeling-based reverse dosimetry of in vitro data for the prediction of cardiotoxicity in humans, providing a novel testing strategy in cardiac safety studies. en application/pdf https://research.wur.nl/en/publications/integrating-in-vitro-data-and-physiologically-based-kinetic-model 10.1007/s00204-020-02766-7 https://edepot.wur.nl/524293 Cardiac electrophysiology Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) Methadone Physiologically based kinetic (PBK) modeling Quantitative in vitro to in vivo extrapolation (QIVIVE) Reverse dosimetry https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic Cardiac electrophysiology
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
Methadone
Physiologically based kinetic (PBK) modeling
Quantitative in vitro to in vivo extrapolation (QIVIVE)
Reverse dosimetry
Cardiac electrophysiology
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
Methadone
Physiologically based kinetic (PBK) modeling
Quantitative in vitro to in vivo extrapolation (QIVIVE)
Reverse dosimetry
spellingShingle Cardiac electrophysiology
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
Methadone
Physiologically based kinetic (PBK) modeling
Quantitative in vitro to in vivo extrapolation (QIVIVE)
Reverse dosimetry
Cardiac electrophysiology
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
Methadone
Physiologically based kinetic (PBK) modeling
Quantitative in vitro to in vivo extrapolation (QIVIVE)
Reverse dosimetry
Shi, Miaoying
Bouwmeester, Hans
Rietjens, Ivonne M.C.M.
Strikwold, Marije
Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
description Development of novel testing strategies to detect adverse human health effects is of interest to replace in vivo-based drug and chemical safety testing. The aim of the present study was to investigate whether physiologically based kinetic (PBK) modeling-facilitated conversion of in vitro toxicity data is an adequate approach to predict in vivo cardiotoxicity in humans. To enable evaluation of predictions made, methadone was selected as the model compound, being a compound for which data on both kinetics and cardiotoxicity in humans are available. A PBK model for methadone in humans was developed and evaluated against available kinetic data presenting an adequate match. Use of the developed PBK model to convert concentration–response curves for the effect of methadone on human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) in the so-called multi electrode array (MEA) assay resulted in predictions for in vivo dose–response curves for methadone-induced cardiotoxicity that matched the available in vivo data. The results also revealed differences in protein plasma binding of methadone to be a potential factor underlying variation between individuals with respect to sensitivity towards the cardiotoxic effects of methadone. The present study provides a proof-of-principle of using PBK modeling-based reverse dosimetry of in vitro data for the prediction of cardiotoxicity in humans, providing a novel testing strategy in cardiac safety studies.
format Article/Letter to editor
topic_facet Cardiac electrophysiology
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
Methadone
Physiologically based kinetic (PBK) modeling
Quantitative in vitro to in vivo extrapolation (QIVIVE)
Reverse dosimetry
author Shi, Miaoying
Bouwmeester, Hans
Rietjens, Ivonne M.C.M.
Strikwold, Marije
author_facet Shi, Miaoying
Bouwmeester, Hans
Rietjens, Ivonne M.C.M.
Strikwold, Marije
author_sort Shi, Miaoying
title Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
title_short Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
title_full Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
title_fullStr Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
title_full_unstemmed Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
title_sort integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
url https://research.wur.nl/en/publications/integrating-in-vitro-data-and-physiologically-based-kinetic-model
work_keys_str_mv AT shimiaoying integratinginvitrodataandphysiologicallybasedkineticmodelingfacilitatedreversedosimetrytopredicthumancardiotoxicityofmethadone
AT bouwmeesterhans integratinginvitrodataandphysiologicallybasedkineticmodelingfacilitatedreversedosimetrytopredicthumancardiotoxicityofmethadone
AT rietjensivonnemcm integratinginvitrodataandphysiologicallybasedkineticmodelingfacilitatedreversedosimetrytopredicthumancardiotoxicityofmethadone
AT strikwoldmarije integratinginvitrodataandphysiologicallybasedkineticmodelingfacilitatedreversedosimetrytopredicthumancardiotoxicityofmethadone
_version_ 1813196750641430528